Kemper Cognitive Wellness is thrilled to be part of an innovative new clinical trial!

 

The Evanthea Dementia Reversal Trial is a randomized, controlled study exploring precision medicine—a groundbreaking approach that combines comprehensive testing with functional and lifestyle interventions to treat mild cognitive impairment and early-stage dementia. This represents a fundamentally different way of understanding and addressing memory loss, offering new hope to those affected.

 

We are honored to be one of only six functional and precision medicine practices nationwide selected to participate in this revolutionary trial. We believe its findings could reshape the future of medicine, transforming how we approach early dementia and cognitive decline.

 

Although the application process for this trial is now closed, Kemper Cognitive Wellness offers a variety of care models and advanced technologies to support brain health. If you have concerns about cognitive decline, we’re here to help. Contact us at HERE, and our team will reach out to you.